EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Silver‐Based Terpyridine Complexes as Antitumor Agents

María Gil-Moles, M Elena Olmos, Miguel Monge, Manuel Beltrán-Visiedo, Isabel Marzo, José M López-de-Luzuriaga, M Concepción Gimeno

Chemistry – A European Journal · 03.07.2023 · 29 (37)

DOI: 10.1002/chem.202300116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 09.05.2023. Verfasst von María Gil-Moles und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química, Universidad de La Rioja, Centro de investigación de Síntesis Química (CISQ), Complejo Científico-Tecnológico, 26004-, Logroñ…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Coordination Complexes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Departamento de Educación, Cultura y Deporte, Gobierno de Aragón.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silver complexes bearing substituted terpyridine or tetra‐2‐pyridinylpyrazine ligands have been prepared and structurally characterised. The study of the anticancer properties of silver complexes with this type of ligands is scarce, despite the possibilities of combining the properties of the metal and the ability of the ligands for DNA binding. Here, the antiproliferative activity, stability, CT‐DNA binding, and mechanism of cell death of these types of derivatives are studied. High cytotoxicity against different tumour cells was observed, and, more important, a great selectivity index has been detected between tumour cells and healthy lymphocytes T for some of these compounds. The CT‐DNA interaction study has shown that these derivatives are able to interact with CT‐DNA by moderate intercalation. Furthermore, cell death studies indicate that these derivatives promote the apoptosis by a mitochondrial pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsCoordination ComplexesHumansStructure-Activity RelationshipSilverLigandsDrug Screening Assays, AntitumorDNACell Line, Tumor

Stichwörter der Autor:innen

cancercytotoxicitypolynuclear compoundssilverterpyridine

Substanzen

SilverLigandsDNAAntineoplastic AgentsCoordination Complexes

Autor:innen und Institutionen

  • Departamento de Química, Universidad de La Rioja, Centro de investigación de Síntesis Química (CISQ), Complejo Científico-Tecnológico, 26004-, Logroño, Spain.
  • Departamento de Bioquímica y Biología Celular, Universidad de Zaragoza-CSIC, 50009, Zaragoza, Spain.
  • Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC-Universidad de Zaragoza, 50009, Zaragoza, Spain.

Förderung

  • Agencia Estatal de Investigación
  • Departamento de Educación, Cultura y Deporte, Gobierno de Aragón

Zitieren

APA

Gil-Moles, M., Olmos, M. E., Monge, M., Beltrán-Visiedo, M., Marzo, I., López-de-Luzuriaga, J. M., & Concepción Gimeno, M. (2023). Silver‐Based Terpyridine Complexes as Antitumor Agents. Chemistry – A European Journal, 29(37). https://doi.org/10.1002/chem.202300116

Vancouver

Gil-Moles M, Olmos ME, Monge M, Beltrán-Visiedo M, Marzo I, López-de-Luzuriaga JM, et al. Silver‐Based Terpyridine Complexes as Antitumor Agents. Chemistry – A European Journal. 2023;29(37). doi:10.1002/chem.202300116

BibTeX
@article{GilMoles2023,
  author = {Gil-Moles, María and Olmos, M Elena and Monge, Miguel and Beltrán-Visiedo, Manuel and Marzo, Isabel and López-de-Luzuriaga, José M and Concepción Gimeno, M},
  title = {Silver‐Based Terpyridine Complexes as Antitumor Agents},
  journal = {Chemistry – A European Journal},
  year = {2023},
  volume = {29},
  number = {37},
  doi = {10.1002/chem.202300116}
}
Kostenlos starten →